Experimental Procedures
All chemicals and solvents were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise noted. Protein standard 1 (PS1), MALDI matrices and targets and ClinProt MB-C3 magnetic beads (C3) were obtained from Bruker Daltonics (Leipzig, Germany). Amicon-4 and Amicon-0.5 Ultra centrifugal filter devices were obtained from Millipore (Billerica, MA, USA). A quality control (QC) serum sample was prepared by pooling human serum from a controlled normal group as previously described. [18] Six different MALDI target preparations and 23 different serum fractionations were prepared to compare MALDI profiling in the LMW range (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . Details are given in the following section.
Mass spectra were acquired in linear and reflectron positive ion mode using an Ultraflex III  MALDI-TOF/TOF mass spectrometer (Bruker Daltonics). The instrument is equipped with a smartbeam  laser, and acquisition laser power was optimized using the PS1 calibration mixture before the collection of sample data. Instrument settings, optimized for mass range m/z 0-20 000, were as follows: ion source 1 = 25.0 kV, ion source 2 = 23.7 kV, lens voltage = 6.0 kV, pulsed ion extraction time = 200 ns, matrix suppression mass cut off = 1500, ADC offset = 50, pre-amplifier filter bandwidth = high, digitizer sampling frequency = 500 MHz. All spectra were generated by averaging 1000 shots from 10 nonoverlapping positions (100 shots/position).
Results and Discussion

MALDI spotting
Clinical profiling of body fluids by MALDI-MS is highly influenced by the choice of MALDI spotting and sample preparation techniques. Our goal was to determine an optimal method for MALDI profiling of LMW serum protein/peptide ions, based on analytical performance measurements of resolution, sensitivity, reproducibility and broad mass range coverage. For sample/matrix crystal preparation, α-cyano-4-hydroxycinnamic acid (CHCA) and sinapinic acid (SA) are most commonly used. Resolution and sensitivity comparisons of these two matrices are well documented in the literature; however, reproducibility studies are limited. Because reproducibility is one of the most critical elements in profiling studies, our main focus was to optimize reproducibility over the LMW serum mass range (<20 kDa), without undermining other performance factors. We evaluated a variety of matrices, sample/matrix ratios, ionic liquid additives, target plates and spotting methods. We narrowed down the principal comparisons to CHCA versus SA matrix (with no additives); Bruker AnchorChip (600 µm) versus ground steel targets and dried droplet versus TL spotting methods. The following six MALDI spotting methods were compared in detail (target-matrix-spotting technique):
For the dried droplet (DD) method, matrices were dissolved in 50% ACN, 0.1% TFA, (5 mg/ml CHCA or saturated SA). Samples were mixed with matrix in the ratio of 1 : 5, then 1 µl was spotted onto an AnchorChip or ground steel plate. For our modified TL method, 0.3 µl of matrix solution (CHCA saturated in MeOH or SA saturated in EtOH) was deposited onto the ground steel target as a seed layer. Protein sample is mixed with matrix solution as above, followed by 1 µl deposited onto the seed layer.
PS1 contains a good spread of ion signals in the range of 3-20 kDa and was used to compare the different MALDI spotting methods. The PS1 mixture contains insulin (5734 Da), ubiquitin (8565 Da), cytochrome c (12 361 Da) and myoglobin (16 952 Da). PS1 was spotted ten times for each preparation. A quick visual inspection showed the TL method to be far superior to the more common DD method in the 3-20 kDa range. An advantage of the TL method is the very homogeneous size of microcrystals. [19] On deposition of the seed layer, the solution quickly spreads and evaporates almost instantaneously (<2 s) leaving an ultra-thin uniform coating. The method generally yields higher resolution spectra, and the detection limit is increased compared with the DD method.
Of the six preparations, three were then statistically compared: CHCA-DD on AnchorChip, CHCA-TL on steel plate and SA-TL on steel plate. Signal processing was performed on raw PS1 spectra to enhance signal to noise (SNR). Processing algorithms, described by Malyarenko et al. [20] included analytical model baseline subtraction, integrative downsampling optimal linear filtering, pedestal removal, peak detection and alignment. Noise-level spectra were estimated by finding the standard deviation of the noise in the down-sampled spectra and adjusting for the expected effect of filtering. Poisson dependence on baseline amplitude was included to account for the observed dark current amplification for early TOF. Integrated down-sampled signal intensities were compared to exclude the influence of the originally different peak widths. Implementation details and Matlab toolbox for signal processing are available from matlabcentral/fileexchange/24469. Metrics for 9 m/z peaks common to each of the three preparations included: measured ion intensity, estimated noise, SNR, normalized intensity, normalized SNR and %CV. Figure 1 shows the mean raw spectra for each of the three preparations. The top spectrum (SA spotted with the TL method on ground steel) proved to be of highest quality based on SNR and reproducibility. Compared with CHCA on Anchorchip, SA on steel produced 3.5× greater average signal intensity and 10× greater average SNR (based on the average values for all peaks and replicates for each sample preparation); whereas TL methods on steel produced similar ion signals for both CHCA and SA. Noise was greatly reduced with SA (1/3.5) giving an overall 3× increase in SNR for SA over CHCA on steel. Comparing individual ion signals in Fig. 1 shows that five of the nine ions have higher signals for CHCA on steel than for SA on steel. However, only two of these ions (ubiquitin 3 + and 2 + ) have higher SNR (with only 1.5× increase).
In the literature, the utilization of TL preps have focused generally on increasing signal and reproducibility of peptides (m/z <4000) using CHCA [21, 22] or higher mass proteins (m/z >10 000) using SA. [23, 24] However, our interest is in the middle range -m/z 3000-20 000 -where LMW serum protein peaks are commonly found. As Fig. 1 demonstrates, we determined SA is a better matrix over CHCA in our modified TL method, due to the reduced noise, higher SNR and resolution that SA offers in the 3-20 kDa range.
Coefficients of variation (%CV) were calculated for experimental replicates for each m/z peak based on normalized intensity and normalized SNR. Table 1 presents the %CV for each peak and for each surface preparation. The average %CVs for a given preparation are shown at the bottom of the table. Reproducibility was comparable whether wileyonlinelibrary.com/journal/jms using normalized intensity or SNR. All preps gave good within-day reproducibility; however, the TL prep with SA on steel was slightly better (%CV = 9.5). Our previous studies for reproducibility of calibration spectra [25] indicated that under carefully preserved instrumental settings, the %CV does not exceed 10% in the course of several months. This confirmed that the major contribution to the variability of MS signals comes from the sample preparation step rather than the instrument or time of the study.
Ultrafiltration
Human QC serum samples [26] were used with Millipore Amicon ultrafiltration devices to optimize MALDI profiling of the LMW serum fraction. [27] Devices were used according to the manufacturer's recommendations. Twenty-three comparisons were made depending on: (1) MWCO: 3, 10, 30, 50 and 100 K, (2) collecting filtrate or retentate, (3) filter size: 0.5 or 4 ml, (4) double filter combinations, (5) denaturation and (5) MB-C3 purification.
A list of these combination preparations can be found in the Supporting Information. All samples were MALDI spotted using the TL method with SA on ground steel. For the MWCO, we found that serum filtrate from the 50K filter gave the best profile in the 3-20 kDa range. This was enhanced by pre-filtration protein denaturation with 2% TFA and post-filtration C3 magnetic bead desalting. Other filtrations that gave complimentary profiles (but less overall coverage in the 3-20 kDa range) included the 10K retentate and combination 50K filtrate followed by 3K retentate (data not shown). The filter size did not matter unless double filtrations were performed (0.5 ml filter for the second filtration). Figure 2 shows MALDI spectra of processed serum. Figure 2(a) is a typical profile of C3 magnetic bead processed QC serum. Figure 2(b) is 50K filtered QC serum followed by C3 bead cleanup. In comparison, noise is greatly reduced for the filtered sample which enhanced peaks in the m/z 2000-6000 range. Adding upfront 2% TFA denaturation (Fig. 2(c) ), noise is further reduced with enhanced peaks in the m/z 7000-10 000 range.
The reproducibility of the two-step serum preparation was determined based on variation in peak intensities and normalized SNR. The systematic reproducibility study was performed only for the best preparation method (Fig. 2(c) ), since other methods did not provide the desired signal gain over the full LMW range. Eight separate aliquots of QC serum (eight biological replicates) underwent 50 kDa centrifugal ultrafiltration and C3 magnetic bead purification. Prepared aliquots were spotted 10 times (10 experimental replicates) on a MALDI target. Raw QC spectra were processed using the same procedures (with slightly different parameters) as the PS1 spectra. Sixteen m/z peaks were selected for comparison. From the data, we found that intensity CVs were not correlated to the m/z value or mean intensity value of a peak. In other words, the variation of a peak's intensity is independent of the absolute value of m/z and intensity. This has been observed previously in MALDI profiling studies. [16, 28] Table 2 presents %CV values for each peak in each aliquot based on normalized SNR. The ranges for %CV for each peak across all aliquots are given in the second column from the right. The column to the far right contains between sample %CV values calculated using data from all replicates, both experimental and biological (74 replicates). The average within and between sample %CVs are summarized at the bottom of the table. No single aliquot yielded the highest or lowest %CV for all peaks. There was no relationship found between %CV and average intensity, noise or SNR.
The average CV per experimental replicate ranged from 8 to 23%, with a mean CV of 12% within samples. The mean CV between samples ranged between 13 and 47%, with an average of 25%. While this sample-to-sample reproducibility of 25% is not very noteworthy, it is within the range of CVs regularly observed in serum MS profiling assays. [16, 18, 28, 29] Of greater note is that the additional sample processing steps -ultrafiltration, C3 -did not significantly impact within sample reproducibility (12% for serum with ultrafiltration/C3 compares well with 9% for PS1 without). Additionally, the MALDI profiling is greatly enhanced in the LMW serum protein range.
In conclusion, currently there is debate as to the diagnostic utility of LMW protein/peptide signatures since all the potential markers to date correspond to proteolytic fragments of the most abundant plasma proteins. [8, 30] However, our ultrafiltration/MALDI method extensively improves peptide/protein peak intensities and reproducibility in the 3-20 kDa range. Our preliminary results (data not shown) comparing prostate cancer to normal serum samples indicate significant peak differences in the LMW range. For future work, we plan to conduct a larger LMW serum clinical profiling study of prostate cancer-related samples using our denaturing ultrafiltration technique.
